Jazz Pharma Appoints New CLO, Renews CFO Agreement
Ticker: JAZZ · Form: 8-K · Filed: May 31, 2024 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | May 31, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, employment-agreement
TL;DR
Jazz Pharma shuffles execs: Renée Smith is new CLO, CFO Miller's contract renewed.
AI Summary
Jazz Pharmaceuticals plc announced on May 31, 2024, changes in its executive team. The company appointed Renée Smith as Chief Legal Officer and General Counsel, effective June 3, 2024. Additionally, Jazz Pharmaceuticals plc entered into a new employment agreement with its Chief Financial Officer, Michael Miller, effective May 31, 2024.
Why It Matters
These executive changes and agreements are crucial for the company's leadership stability and strategic direction in the pharmaceutical sector.
Risk Assessment
Risk Level: low — The filing primarily concerns routine executive appointments and employment agreements, which typically carry low inherent risk.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- Renée Smith (person) — Appointed Chief Legal Officer and General Counsel
- Michael Miller (person) — Chief Financial Officer
- June 3, 2024 (date) — Effective date for Renée Smith's appointment
- May 31, 2024 (date) — Effective date for Michael Miller's employment agreement
FAQ
Who has been appointed as the new Chief Legal Officer and General Counsel at Jazz Pharmaceuticals?
Renée Smith has been appointed as the new Chief Legal Officer and General Counsel, effective June 3, 2024.
When is Renée Smith's appointment as Chief Legal Officer and General Counsel effective?
Renée Smith's appointment is effective June 3, 2024.
Has Jazz Pharmaceuticals entered into a new employment agreement with its CFO?
Yes, Jazz Pharmaceuticals plc entered into a new employment agreement with its Chief Financial Officer, Michael Miller, effective May 31, 2024.
Who is the current Chief Financial Officer of Jazz Pharmaceuticals?
Michael Miller is the Chief Financial Officer of Jazz Pharmaceuticals.
What is the effective date of the new employment agreement for Michael Miller?
The new employment agreement for Michael Miller is effective May 31, 2024.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2024-05-31 17:01:02
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d834982d8k.htm (8-K) — 20KB
- 0001193125-24-151941.txt ( ) — 142KB
- jazz-20240531.xsd (EX-101.SCH) — 3KB
- jazz-20240531_lab.xml (EX-101.LAB) — 18KB
- jazz-20240531_pre.xml (EX-101.PRE) — 11KB
- d834982d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Neena Patil Name: Neena Patil Title: Executive Vice President and Chief Legal Officer Date: May 31, 2024